RxDoctor Payments Data

Ashley Lindsey

Psychiatric/Mental Health · Jeffersonville, INNPI 1548563208

Payments from drug & device makers

$4,167in general payments, 2019–2025

Across 343 payments — averaging $12.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$789
  • Sunovion Pharmaceuticals Inc.$434
  • Alkermes, Inc.$304
  • Supernus Pharmaceuticals, Inc.$286
  • Otsuka America Pharmaceutical, Inc.$272
  • plus $980 from 17 others

What the payments were for

  • Food & beverage$4,10899%
  • Education$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,167 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$13,530
Medicare patients
68
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl62$88,475
RexultiBrexpiprazole31$44,868
Aripiprazole143$32,921
Wellbutrin XlBupropion Hcl11$32,906
FanaptIloperidone14$30,920
TrintellixVortioxetine Hydrobromide30$25,694
Abilify MaintenaAripiprazole12$24,472
MounjaroTirzepatide15$15,656
QelbreeViloxazine Hcl24$12,328
VyvanseLisdexamfetamine Dimesylate28$10,908
ProzacFluoxetine Hcl11$9,446
Seroquel XrQuetiapine Fumarate11$9,368
Lurasidone Hcl14$8,733
Desvenlafaxine Succinate ErDesvenlafaxine Succinate54$5,511
Asenapine Maleate12$3,481

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,103$88,47562 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$272$69,34043 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$96$36,60258 claims
Vanda Pharmaceuticals Inc.Fanapt$98$30,92014 claims
Supernus Pharmaceuticals, Inc.Qelbree$286$12,32824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Jeffersonville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →